Posted in | News | Business

Vision Analytical Highlights Emerging Role of Dynamic Image Analysis in USP <1788> Subvisible Particle Testing

Vision Analytical Inc., a leader in particle size and shape analysis, today announced new insights into the evolving role of analytical techniques in subvisible particle characterization, particularly in the context of United States Pharmacopeia (USP) Chapter <1788>.

Subvisible particle analysis remains a critical component in the development and quality control of biologics, where particle size, morphology, and composition can significantly impact product stability, efficacy, and patient safety. While traditional methods such as light obscuration have long been used for compendial testing, emerging regulatory guidance and scientific understanding are driving increased interest in orthogonal techniques that provide additional particle characterization.

USP <1788>, which addresses methods for determining subvisible particle size distribution, emphasizes the importance of using complementary analytical approaches to better understand particle populations. This shift reflects broader industry recognition that particle characterization extends beyond simple size measurement.

“Subvisible particle analysis is no longer just about counting particles within a size range,” said Peter Bouza, President of Vision Analytical. “There is a growing need to understand particle morphology, differentiate between intrinsic and extrinsic particles, and identify potential sources of contamination. These are areas where advanced imaging techniques can provide significant value.”

Dynamic Image Analysis (DIA) is one such technique gaining attention for its ability to provide both size and shape information, along with visual confirmation through particle imaging. These capabilities can support more informed decision-making during formulation development, process optimization, and root cause investigations.

As the biopharmaceutical industry continues to evolve, the integration of complementary analytical methods is expected to play an increasingly important role in ensuring product quality and regulatory compliance.

Vision Analytical is actively engaged in supporting the industry’s transition toward more comprehensive particle characterization strategies through educational initiatives, application studies, and collaboration with regulatory and scientific communities.

For more information on subvisible particle analysis and emerging methodologies, visit www.ParticleShape.com.

About Vision Analytical Inc.

Vision Analytical Inc. specializes in advanced particle size and shape analysis solutions, leveraging Dynamic Image Analysis technology to provide detailed particle characterization across a range of industries, including pharmaceuticals, fuels, and materials science.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Vision Analytical Inc.. (2026, April 17). Vision Analytical Highlights Emerging Role of Dynamic Image Analysis in USP <1788> Subvisible Particle Testing. AZoM. Retrieved on April 17, 2026 from https://www.azom.com/news.aspx?newsID=65349.

  • MLA

    Vision Analytical Inc.. "Vision Analytical Highlights Emerging Role of Dynamic Image Analysis in USP <1788> Subvisible Particle Testing". AZoM. 17 April 2026. <https://www.azom.com/news.aspx?newsID=65349>.

  • Chicago

    Vision Analytical Inc.. "Vision Analytical Highlights Emerging Role of Dynamic Image Analysis in USP <1788> Subvisible Particle Testing". AZoM. https://www.azom.com/news.aspx?newsID=65349. (accessed April 17, 2026).

  • Harvard

    Vision Analytical Inc.. 2026. Vision Analytical Highlights Emerging Role of Dynamic Image Analysis in USP <1788> Subvisible Particle Testing. AZoM, viewed 17 April 2026, https://www.azom.com/news.aspx?newsID=65349.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.